• 1
    Chen K, Lin Y, Detwiler TC. Protein disulfide isomerase activity is released by activated platelets. Blood 1992; 79: 22268.
  • 2
    Jordan PA, Stevens JM, Hubbard GP, Barrett NE, Sage T, Authi KS, Gibbins JM. A role for the thiol isomerase protein ERP5 in platelet function. Blood 2005; 105: 15007.
  • 3
    Holbrook LM, Watkins NA, Simmonds AD, Jones CI, Ouwehand WH, Gibbins JM. Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation. Br J Haematol 2010; 148: 62737.
  • 4
    Essex DW, Chen K, Swiatkowska M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood 1995; 86: 216873.
  • 5
    Lahav J, Gofer-Dadosh N, Luboshitz J, Hess O, Shaklai M. Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett 2000; 475: 8992.
  • 6
    Essex DW, Li M. Protein disulphide isomerase mediates platelet aggregation and secretion. Br J Haematol 1999; 104: 44854.
  • 7
    Chen K, Detwiler TC, Essex DW. Characterization of protein disulphide isomerase released from activated platelets. Br J Haematol 1995; 90: 42531.
  • 8
    Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 2008; 118: 112331.
  • 9
    Reinhardt C, von Bruhl ML, Manukyan D, Grahl L, Lorenz M, Altmann B, Dlugai S, Hess S, Konrad I, Orschiedt L, Mackman N, Ruddock L, Massberg S, Engelmann B. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 2008; 118: 111022.
  • 10
    Hirano N, Shibasaki F, Kato H, Sakai R, Tanaka T, Nishida J, Yazaki Y, Takenawa T, Hirai H. Molecular cloning and characterization of a cDNA for bovine phospholipase C-alpha: proposal of redesignation of phospholipase C-alpha. Biochem Biophys Res Commun 1994; 204: 37582.
  • 11
    Hirano N, Shibasaki F, Sakai R, Tanaka T, Nishida J, Yazaki Y, Takenawa T, Hirai H. Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and inducible expression by the oncogenic transformation. Eur J Biochem 1995; 234: 33642.
  • 12
    Ferrari DM, Soling HD. The protein disulphide-isomerase family: unravelling a string of folds. Biochem J 1999; 339: 110.
  • 13
    Frickel EM, Frei P, Bouvier M, Stafford WF, Helenius A, Glockshuber R, Ellgaard L. ERp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol Chem 2004; 279: 1827787.
  • 14
    Daniels R, Kurowski B, Johnson AE, Hebert DN. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol Cell 2003; 11: 7990.
  • 15
    Antoniou AN, Ford S, Alphey M, Osborne A, Elliott T, Powis SJ. The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules. EMBO J 2002; 21: 265563.
  • 16
    Li Y, Camacho P. Ca2+-dependent redox modulation of SERCA 2b by ERp57. J Cell Biol 2004; 164: 3546.
  • 17
    Grillo C, Coppari S, Turano C, Altieri F. The DNA-binding activity of protein disulfide isomerase ERp57 is associated with the a(‘) domain. Biochem Biophys Res Commun 2002; 295: 6773.
  • 18
    Grillo C, D’Ambrosio C, Scaloni A, Maceroni M, Merluzzi S, Turano C, Altieri F. Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors. Free Radic Biol Med 2006; 41: 111323.
  • 19
    Ellerman DA, Myles DG, Primakoff P. A role for sperm surface protein disulfide isomerase activity in gamete fusion: evidence for the participation of ERp57. Dev Cell 2006; 10: 8317.
  • 20
    Hodgkinson SC, Lowry PJ. Selective elution of immunoadsorbed anti-(human prolactin) immunoglobulins with enhanced immunochemical properties. Biochem J 1982; 205: 53541.
  • 21
    Raturi A, Mutus B. Characterization of redox state and reductase activity of protein disulfide isomerase under different redox environments using a sensitive fluorescent assay. Free Radic Biol Med 2007; 43: 6270.
  • 22
    Robinson A, Gibbins J, Rodriguez-Linares B, Finan PM, Wilson L, Kellie S, Findell P, Watson SP. Characterization of Grb2-binding proteins in human platelets activated by Fc gamma RIIA cross-linking. Blood 1996; 88: 52230.
  • 23
    Spyridon M, Moraes LA, Jones CI, Sage T, Sasikumar P, Bucci G, Gibbins JM. LXR as a novel antithrombotic target. Blood 2011; 117: 575161.
  • 24
    Jones CI, Garner SF, Moraes LA, Kaiser WJ, Rankin A, Ouwehand WH, Goodall AH, Gibbins JM. PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways. FEBS Lett 2009; 583: 361824.
  • 25
    Kulkarni S, Nesbitt WS, Dopheide SM, Hughan SC, Harper IS, Jackson SP. Techniques to examine platelet adhesive interactions under flow. Methods Mol Biol 2004; 272: 16586.
  • 26
    Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso C. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994; 216: 44450.
  • 27
    Falati S, Patil S, Gross PL, Stapleton M, Merrill-Skoloff G, Barrett NE, Pixton KL, Weiler H, Cooley B, Newman DK, Newman PJ, Furie BC, Furie B, Gibbins JM. Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 2006; 107: 53541.
  • 28
    Robinson A, O’Neill S, Kiernan A, O’Donoghue N, Moran N. Bacitracin reveals a role for multiple thiol isomerases in platelet function. Br J Haematol 2006; 132: 33948.
  • 29
    Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999; 103: 22938.
  • 30
    Solda T, Garbi N, Hammerling GJ, Molinari M. Consequences of ERp57 deletion on oxidative folding of obligate and facultative clients of the calnexin cycle. J Biol Chem 2006; 281: 621926.
  • 31
    Sun QH, Liu CY, Wang R, Paddock C, Newman PJ. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes. Blood 2002; 100: 2094101.
  • 32
    Schulz C, Leuschen NV, Frohlich T, Lorenz M, Pfeiler S, Gleissner CA, Kremmer E, Kessler M, Khandoga AG, Engelmann B, Ley K, Massberg S, Arnold GJ. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood 2010; 115: 410210.